导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -16.99% | 954/1050 |
| 近一周 | -3.87% | 1019/1104 |
| 近一月 | -4.68% | 737/1103 |
| 近一季 | -4.97% | 472/1092 |
| 近半年 | -19.19% | 989/1070 |
| 近一年 | -20.92% | 915/1018 |
| 近两年 | 38.93% | 601/926 |
| 近三年 | 10.58% | 590/834 |
| 成立以来 | 94.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.45% 740/1070 |
-13.54% 989/1101 |
- - |
- - |
| 2025 | 22.55% 623/1065 |
5.12% 404/1014 |
8.10% 154/1038 |
11.50% 826/1050 |
-3.29% 619/1065 |
| 2024 | 6.77% 369/1011 |
2.46% 192/960 |
-18.49% 948/983 |
20.23% 63/991 |
6.34% 109/1011 |
| 2023 | 13.69% 13/952 |
44.48% 1/880 |
-0.11% 198/895 |
-19.13% 850/915 |
-2.60% 283/952 |
| 2022 | -33.54% 690/867 |
-18.04% 427/773 |
-7.63% 767/806 |
-18.63% 728/845 |
7.89% 118/867 |
| 2021 | 35.79% 46/740 |
6.18% 39/580 |
13.62% 270/659 |
-8.90% 478/704 |
23.56% 3/740 |
| 2020 | 47.52% 249/554 |
-1.55% 198/419 |
25.76% 183/466 |
10.62% 237/517 |
7.71% 397/554 |
| 2019 | 50.23% 147/410 |
32.19% 253/1146 |
1.29% 224/1228 |
10.45% 105/390 |
1.58% 382/410 |
| 2018 | -24.17% 132/349 |
- - |
0.49% 65/990 |
-10.17% 766/1000 |
-13.34% 776/1080 |
| 2017 | 9.42% 136/285 |
- - |
- - |
- - |
- - |
| 2016 | -25.84% 138/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 招商体育文化休闲股票A VS. 东吴新产业精选股票A(580008) |